FDA Rejects Oral Treatment for Type 1 Diabetes – Wall Street Journal
Business News FDA Rejects Oral Treatment for Type 1 Diabetes Wall Street Journal FDA stiff-arms Sanofi and Lexicon’s Type 1 diabetes hopeful Zynquista FiercePharma FDA snubs Sanofi, Lexicon on their pitch for SGLT1/2 diabetes drug sotagliflozin, companies mum on what went wrong Endpoints News Why Zuora, Greenbrier, and Lexicon Pharmaceuticals Slumped Today Motley Fool Diabetes Treatment: Sanofi Slips After […]